2 ARMS/GROUPS: DICHOTOMOUS OUTCOMES (e.g. OR, RR, %death)

UI Author Year Outcome Exposure/Intervention Mean Follow-up, mo N Event N Total Outcome Metric (e.g. OR, RR, HR, %) and direction of comparison * Unadjusted Adjusted
Result 95% CI P btw Result 95% CI P btw
17440943 Mikhak 2007 Total prostate cancer 25(OH)D <= 15 ng/ml Nd 627 1231 OR: 25(OH)D deficient/non- deficient 0.63 0.44–0.90 nd 0.62 0.43–0.91 0.01
25(OH)D > 15 ng/ml Nd 57 145
Total prostate cancer 1,25(OH)D <= 26 pg/ml Nd 565 1151 OR: 1,25(OH)D deficient/non-deficient 1.22 0.89–1.65 nd 1.25 0.91–1.73 nd
1,25(OH)D > 26 pg/ml Nd 119 225
*

Example: OR Ca/placebo

Note: unadjusted model still matched for matching factors as listed in confounder table

From: Appendix C, Evidence Tables: L-Q

Cover of Vitamin D and Calcium
Vitamin D and Calcium: A Systematic Review of Health Outcomes.
Evidence Reports/Technology Assessments, No. 183.
Chung M, Balk EM, Brendel M, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.